The 17 analysts offering 12-month price forecasts for Abbott Laboratories have a median target of 145.00, with a high estimate of 157.00 and a low estimate of 110.00. The median estimate represents a +15.00% increase from the last price of 126.09.
The current consensus among 23 polled investment analysts is to Buy stock in Abbott Laboratories. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.20
Reporting Date Jan 26
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.